GBS (GBS) Competitors $1.35 +0.07 (+5.47%) As of 05/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock GBS vs. SRTS, NSPR, INO, ICCM, CTSO, GUTS, NVNO, MODD, TELA, and DXRShould you be buying GBS stock or one of its competitors? The main competitors of GBS include Sensus Healthcare (SRTS), InspireMD (NSPR), Inovio Pharmaceuticals (INO), IceCure Medical (ICCM), Cytosorbents (CTSO), Fractyl Health (GUTS), enVVeno Medical (NVNO), Modular Medical (MODD), TELA Bio (TELA), and Daxor (DXR). These companies are all part of the "surgical & medical instruments" industry. GBS vs. Sensus Healthcare InspireMD Inovio Pharmaceuticals IceCure Medical Cytosorbents Fractyl Health enVVeno Medical Modular Medical TELA Bio Daxor GBS (NYSE:GBS) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Does the media favor GBS or SRTS? In the previous week, Sensus Healthcare had 3 more articles in the media than GBS. MarketBeat recorded 4 mentions for Sensus Healthcare and 1 mentions for GBS. GBS's average media sentiment score of 0.65 beat Sensus Healthcare's score of 0.51 indicating that GBS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GBS 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in GBS or SRTS? 2.8% of GBS shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 0.3% of GBS shares are held by company insiders. Comparatively, 9.4% of Sensus Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate GBS or SRTS? Sensus Healthcare has a consensus price target of $13.00, suggesting a potential upside of 198.51%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than GBS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GBS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Is GBS or SRTS more profitable? Sensus Healthcare has a net margin of 15.90% compared to GBS's net margin of 0.00%. Sensus Healthcare's return on equity of 12.60% beat GBS's return on equity.Company Net Margins Return on Equity Return on Assets GBSN/A -85.64% -54.42% Sensus Healthcare 15.90%12.60%11.38% Does the MarketBeat Community believe in GBS or SRTS? Sensus Healthcare received 186 more outperform votes than GBS when rated by MarketBeat users. CompanyUnderperformOutperformGBSN/AN/ASensus HealthcareOutperform Votes18668.89% Underperform Votes8431.11% Which has more volatility and risk, GBS or SRTS? GBS has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Which has higher earnings & valuation, GBS or SRTS? Sensus Healthcare has higher revenue and earnings than GBS. GBS is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGBS$440K45.69-$8.31M-$0.56-2.41Sensus Healthcare$41.81M1.72$6.65M$0.4010.89 SummarySensus Healthcare beats GBS on 15 of the 18 factors compared between the two stocks. Get GBS News Delivered to You Automatically Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBS vs. The Competition Export to ExcelMetricGBSSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$20.10M$4.35B$5.53B$19.18BDividend YieldN/A39.93%5.09%4.00%P/E Ratio-2.4130.0622.7133.31Price / Sales45.6956.35408.9928.98Price / CashN/A51.0838.1817.52Price / Book3.076.136.844.54Net Income-$8.31M$68.15M$3.22B$1.02B7 Day Performance3.85%0.47%2.11%1.86%1 Month Performance-9.40%-2.17%3.51%-2.34%1 Year Performance-49.25%21.25%16.31%5.13% GBS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBSGBSN/A$1.35+5.5%N/A-51.7%$20.10M$440,000.00-2.417Gap DownSRTSSensus Healthcare2.3992 of 5 stars$4.61-3.5%$13.00+182.3%+19.9%$75.88M$41.81M11.5040Upcoming EarningsNews CoverageNSPRInspireMD2.5046 of 5 stars$2.42+4.3%$4.75+96.4%+32.7%$74.11M$7.01M-3.2350INOInovio Pharmaceuticals3.4624 of 5 stars$1.92+1.3%$12.20+537.1%-83.7%$70.23M$217,756.00-0.48320Positive NewsICCMIceCure Medical2.7384 of 5 stars$1.27+4.1%$2.50+96.9%-0.9%$70.21M$3.29M-4.3660Short Interest ↓Gap UpCTSOCytosorbents1.9206 of 5 stars$1.07-1.8%$4.67+336.1%+20.1%$66.88M$35.59M-2.97220Upcoming EarningsAnalyst ForecastGUTSFractyl Health1.7366 of 5 stars$1.28+6.3%$11.00+762.7%-81.0%$62.37M$93,000.00-0.10102NVNOenVVeno Medical1.5843 of 5 stars$2.91+5.1%N/A-35.5%$51.29MN/A-2.2719Earnings ReportUpcoming EarningsNews CoveragePositive NewsMODDModular Medical1.9679 of 5 stars$1.00-1.9%N/A-33.5%$40.71MN/A-1.8920Short Interest ↓TELATELA Bio3.1086 of 5 stars$0.96-0.1%$7.25+656.8%-78.4%$37.89M$69.30M-0.57120Upcoming EarningsShort Interest ↓News CoveragePositive NewsGap UpDXRDaxor4.128 of 5 stars$7.32-2.7%$25.00+241.5%-20.6%$35.41M$2.13M0.0037Gap Up Related Companies and Tools Related Companies Sensus Healthcare Alternatives InspireMD Alternatives Inovio Pharmaceuticals Alternatives IceCure Medical Alternatives Cytosorbents Alternatives Fractyl Health Alternatives enVVeno Medical Alternatives Modular Medical Alternatives TELA Bio Alternatives Daxor Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GBS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GBS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GBS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
